Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-054284

Chief Medical Officer sold 12,500 shares at an average $41.74 ($521,795)

  • Chief Medical Officer acquired 12,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pang Phillip Chief Medical Officer 2020-10-07 Option exercise +10,185 $1.53 $15,583 39,962 D: show line 1 in the form
Pang Phillip Chief Medical Officer 2020-10-07 Option exercise +2,315 $1.58 $3,646 42,277 D: show line 2 in the form
Pang Phillip Chief Medical Officer 2020-10-07 Sale −7,500 $41.76 $313,166 34,777 D: show line 3 in the form
Pang Phillip Chief Medical Officer 2020-10-07 Sale −5,000 $41.73 $208,629 29,777 D: show line 4 in the form
Open-market sales · 12,500 sh · avg $41.74 · $521,795

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pang Phillip Chief Medical Officer 2020-10-07 Option exercise · Employee Stock Option (Right to Buy) −10,185 100,461 D: show line 5 in the form
Pang Phillip Chief Medical Officer 2020-10-07 Option exercise · Employee Stock Option (Right to Buy) −2,315 50,927 D: show line 6 in the form
Loading xslF345X03/doc4.xml…